252 related articles for article (PubMed ID: 33788737)
1. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
[TBL] [Abstract][Full Text] [Related]
3. Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.
Kaufmann S; Horger T; Oelker A; Kloth C; Nikolaou K; Schulze M; Horger M
Eur J Radiol; 2015 Jun; 84(6):1029-35. PubMed ID: 25816994
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
5. Multiphasic Dynamic Computed Tomography Evaluation of Liver Tissue Perfusion Characteristics Using the Dual Maximum Slope Model in Patients With Cirrhosis and Hepatocellular Carcinoma: A Feasibility Study.
Lee DH; Lee JM; Klotz E; Han JK
Invest Radiol; 2016 Jul; 51(7):430-4. PubMed ID: 26756941
[TBL] [Abstract][Full Text] [Related]
6. Application of 128 slice 4D CT whole liver perfusion imaging in hepatic tumor.
Guo M; Yu Y
Cell Biochem Biophys; 2014 Sep; 70(1):173-8. PubMed ID: 24691926
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
[No Abstract] [Full Text] [Related]
8. Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.
Fischer MA; Kartalis N; Grigoriadis A; Loizou L; Stål P; Leidner B; Aspelin P; Brismar TB
Eur Radiol; 2015 Nov; 25(11):3123-32. PubMed ID: 25903707
[TBL] [Abstract][Full Text] [Related]
9. Quantitative hepatic CT perfusion measurement: comparison of Couinaud's hepatic segments with dual-source 128-slice CT.
Wang X; Xue HD; Jin ZY; Su BY; Li Z; Sun H; Chen Y; Liu W
Eur J Radiol; 2013 Feb; 82(2):220-6. PubMed ID: 23083523
[TBL] [Abstract][Full Text] [Related]
10. VEGFR-2 expression in HCC, dysplastic and regenerative liver nodules, and correlation with pre-biopsy Dynamic Contrast Enhanced CT.
Thaiss WM; Kaufmann S; Kloth C; Nikolaou K; Bösmüller H; Horger M
Eur J Radiol; 2016 Nov; 85(11):2036-2041. PubMed ID: 27776657
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of perfusion CT in hepatocellular carcinoma treatment with sorafenib: comparison with mRECIST in longitudinal follow-up.
Kaufmann S; Thaiss WM; Schulze M; Bitzer M; Lauer U; Nikolaou K; Horger M
Acta Radiol; 2018 Jul; 59(7):765-772. PubMed ID: 28927298
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.
Ippolito D; Capraro C; Casiraghi A; Cestari C; Sironi S
Eur Radiol; 2012 Apr; 22(4):803-11. PubMed ID: 22086560
[TBL] [Abstract][Full Text] [Related]
13. Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: Impact on tumor and liver parenchymal vascularisation.
Kaufmann S; Horger T; Oelker A; Beck S; Schulze M; Nikolaou K; Ketelsen D; Horger M
Eur J Radiol; 2015 Dec; 84(12):2548-54. PubMed ID: 26428842
[TBL] [Abstract][Full Text] [Related]
14. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.
Ippolito D; Sironi S; Pozzi M; Antolini L; Invernizzi F; Ratti L; Leone EB; Fazio F
Eur J Radiol; 2010 Jan; 73(1):148-52. PubMed ID: 19054640
[TBL] [Abstract][Full Text] [Related]
15. Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
Fischer MA; Marquez HP; Gordic S; Leidner B; Klotz E; Aspelin P; Alkadhi H; Brismar TB
Eur Radiol; 2017 Mar; 27(3):1074-1080. PubMed ID: 27368924
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients With Advanced Hepatocellular Carcinoma.
Ippolito D; Querques G; Pecorelli A; Talei Franzesi C; Okolicsanyi S; Strazzabosco M; Sironi S
J Comput Assist Tomogr; 2019; 43(2):206-213. PubMed ID: 30407241
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility and variability of very low dose hepatic perfusion CT in metastatic liver disease.
Topcuoğlu OM; Karçaaltıncaba M; Akata D; Özmen MN
Diagn Interv Radiol; 2016; 22(6):495-500. PubMed ID: 27759566
[TBL] [Abstract][Full Text] [Related]
19. Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
Mulé S; Pigneur F; Quelever R; Tenenhaus A; Baranes L; Richard P; Tacher V; Herin E; Pasquier H; Ronot M; Rahmouni A; Vilgrain V; Luciani A
Eur Radiol; 2018 May; 28(5):1977-1985. PubMed ID: 29168007
[TBL] [Abstract][Full Text] [Related]
20. Perfusion-CT analysis for assessment of hepatocellular carcinoma lesions: diagnostic value of different perfusion maps.
Hatzidakis A; Perisinakis K; Kalarakis G; Papadakis A; Savva E; Ippolito D; Karantanas A
Acta Radiol; 2019 May; 60(5):561-568. PubMed ID: 30114926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
